Deep Dive In Vitiligo
From Easter Island soil to modern skin science — meet rapamycin, the molecule that might just change vitiligo care. Once known mainly as an anti-rejection drug for organ transplants, rapamycin is now being tested as a topical treatment that could both calm the immune attack and help pigment return. Early studies look promising: minimal side effects, slow but steady repigmentation, and surprisingly good tolerance. In this episode, we explore: * How rapamycin rewires the skin’s immune balance * Why it’s called both a suppressor and a rejuvenator * What Phase II trials are revealing so far * And whether this “longevity drug” might also restore color to the skin It’s too early to call it a breakthrough — but this little molecule from a far-off island might just be the next quiet revolution in vitiligo therapy. Full story: Topical Rapamycin: Could This Be Vitiligo’s Next Big Breakthrough? [https://vrfoundation.org/news_items/topical-rapamycin-could-this-be-vitiligos-next-big-breakthrough]
58 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Deep Dive In Vitiligo!